EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Review Article - Pharmacological management of diabetic retinopathy: Current trends and emerging therapies

Maduabuchukwu Innocent Nkollo

Journal of Kenya Assocation of Physicians · 08.04.2026 · 8 (1) · 4-12

DOI: 10.4314/jkap.v8i1.2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Kenya Assocation of Physicians, online erschienen am 08.04.2026. Verfasst von Maduabuchukwu Innocent Nkollo. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetic Retinopathy (DR) is a leading cause of preventable vision loss worldwide. Over the past decade, pharmacological therapies have revolutionized management, shifting emphasis from laser photocoagulation to intravitreal agents.

Objective

This review summarizes current pharmacological treatments, evaluates evidence from pivotal clinical trials, and discusses emerging therapeutic strategies in DR management.

Methods

A narrative synthesis of recent guidelines, clinical trial data, and regulatory updates was undertaken, emphasizing anti-VEGF therapy, dual-pathway inhibition, corticosteroid implants, systemic agents, and emerging therapies.

Results

Anti-VEGF therapy remains the gold standard for Diabetic Macular Edema (DME) and Proliferative DR (PDR), with aflibercept 8mg (Eylea HD) and faricimab (vabysmo) offering improved durability. Corticosteroid implants provide alternatives in refractory or pseudophakic cases. Panretinal photocoagulation remains relevant where adherence is uncertain. Systemic agents, notably fenofibrate, reduce DR progression. Emerging therapies include sustained-delivery systems, gene therapy, integrin inhibitors, and Artificial Intelligence (AI)-assisted screening.

Conclusion

Pharmacological management of DR is in a transition toward extended-dosing, dualmechanism inhibition, and systemic adjunctive therapies. Integration of AI-enabled screening and next-generation therapeutics promises to reduce treatment burden and improve visual outcome.

Zitieren

APA

Nkollo, M. I. (2026). Review Article - Pharmacological management of diabetic retinopathy: Current trends and emerging therapies. Journal of Kenya Assocation of Physicians, 8(1), 4-12. https://doi.org/10.4314/jkap.v8i1.2

Vancouver

Nkollo MI. Review Article - Pharmacological management of diabetic retinopathy: Current trends and emerging therapies. Journal of Kenya Assocation of Physicians. 2026;8(1):4-12. doi:10.4314/jkap.v8i1.2

BibTeX
@article{Nkollo2026,
  author = {Nkollo, Maduabuchukwu Innocent},
  title = {Review Article - Pharmacological management of diabetic retinopathy: Current trends and emerging therapies},
  journal = {Journal of Kenya Assocation of Physicians},
  year = {2026},
  volume = {8},
  number = {1},
  pages = {4--12},
  doi = {10.4314/jkap.v8i1.2}
}
Kostenlos starten →